Sa JK - Search Results

1

Antitumor activity, pharmacokinetics, tumor-homing effect, and hepatotoxicity of a species cross-reactive c-Met antibody.

Park H, Kim D, Son E, Shin S, Sa JK, Kim SH, Yoon Y, Nam DH. Park H, et al. Among authors: sa jk. Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):409-415. doi: 10.1016/j.bbrc.2017.09.061. Epub 2017 Sep 14. Biochem Biophys Res Commun. 2017. PMID: 28917835

2

In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma.

Sa JK, Yoon Y, Kim M, Kim Y, Cho HJ, Lee JK, Kim GS, Han S, Kim WJ, Shin YJ, Joo KM, Paddison PJ, Ishitani T, Lee J, Nam DH. Sa JK, et al. Oncotarget. 2015 Aug 21;6(24):20145-59. doi: 10.18632/oncotarget.3980. Oncotarget. 2015. PMID: 26023737 Free PMC article.

3

Involvement of DDX6 gene in radio- and chemoresistance in glioblastoma.

Cho YJ, Kang W, Kim SH, Sa JK, Kim N, Paddison PJ, Kim M, Joo KM, Hwang YI, Nam DH. Cho YJ, et al. Among authors: sa jk. Int J Oncol. 2016 Mar;48(3):1053-62. doi: 10.3892/ijo.2016.3328. Epub 2016 Jan 11. Int J Oncol. 2016. PMID: 26783102

4

Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy.

Kim DG, Kim KH, Seo YJ, Yang H, Marcusson EG, Son E, Lee K, Sa JK, Lee HW, Nam DH. Kim DG, et al. Among authors: sa jk. Oncotarget. 2016 May 17;7(20):29400-11. doi: 10.18632/oncotarget.8837. Oncotarget. 2016. PMID: 27102443 Free PMC article.

5

Genomic and transcriptomic characterization of skull base chordoma.

Sa JK, Lee IH, Hong SD, Kong DS, Nam DH. Sa JK, et al. Oncotarget. 2017 Jan 3;8(1):1321-1328. doi: 10.18632/oncotarget.13616. Oncotarget. 2017. PMID: 27901492 Free PMC article.

6

Spatiotemporal genomic architecture informs precision oncology in glioblastoma.

Lee JK, Wang J, Sa JK, Ladewig E, Lee HO, Lee IH, Kang HJ, Rosenbloom DS, Camara PG, Liu Z, van Nieuwenhuizen P, Jung SW, Choi SW, Kim J, Chen A, Kim KT, Shin S, Seo YJ, Oh JM, Shin YJ, Park CK, Kong DS, Seol HJ, Blumberg A, Lee JI, Iavarone A, Park WY, Rabadan R, Nam DH. Lee JK, et al. Among authors: sa jk. Nat Genet. 2017 Apr;49(4):594-599. doi: 10.1038/ng.3806. Epub 2017 Mar 6. Nat Genet. 2017. PMID: 28263318 Free PMC article.

7

Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling.

Yin J, Oh YT, Kim JY, Kim SS, Choi E, Kim TH, Hong JH, Chang N, Cho HJ, Sa JK, Kim JC, Kwon HJ, Park S, Lin W, Nakano I, Gwak HS, Yoo H, Lee SH, Lee J, Kim JH, Kim SY, Nam DH, Park MJ, Park JB. Yin J, et al. Among authors: sa jk. Cancer Res. 2017 Sep 15;77(18):4973-4984. doi: 10.1158/0008-5472.CAN-17-0388. Epub 2017 Jul 28. Cancer Res. 2017. PMID: 28754668

8

Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain.

Park H, Kim D, Kim E, Sa JK, Lee HW, Yu S, Oh J, Kim SH, Yoon Y, Nam DH. Park H, et al. Among authors: sa jk. Int J Mol Sci. 2017 Sep 13;18(9):1968. doi: 10.3390/ijms18091968. Int J Mol Sci. 2017. PMID: 28902178 Free PMC article.

9

Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth.

Lee J, Shin YJ, Lee K, Cho HJ, Sa JK, Lee SY, Kim SH, Lee J, Yoon Y, Nam DH. Lee J, et al. Among authors: sa jk. Cancer Res Treat. 2018 Jul;50(3):1009-1022. doi: 10.4143/crt.2017.315. Epub 2017 Nov 10. Cancer Res Treat. 2018. PMID: 29129044 Free PMC article.

10

Identification of transcriptome signature for predicting clinical response to bevacizumab in recurrent glioblastoma.

Choi SW, Shin H, Sa JK, Cho HJ, Koo H, Kong DS, Seol HJ, Nam DH. Choi SW, et al. Among authors: sa jk. Cancer Med. 2018 May;7(5):1774-1783. doi: 10.1002/cam4.1439. Epub 2018 Mar 23. Cancer Med. 2018. PMID: 29573206 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters